Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications (Q36050486)

11 August 2017

1 reference

title

Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications (English)

1 reference

11 August 2017

1 reference

Fariya Bukhari

1

1 reference

11 August 2017

Thomas MacGillivray

series ordinal

2

1 reference

11 August 2017

Federica del Monte

series ordinal

3

1 reference

11 August 2017

Roger J Hajjar

series ordinal

4

1 reference

11 August 2017

language of work or name

1 reference

1 January 2005

1 reference

Expert Review of Cardiovascular Therapy

11 August 2017

published in

1 reference

11 August 2017

volume

3

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

85-97

1 reference

Genetic editing of dysfunctional myocardium

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

High efficiency transfection of porcine vascular cells in vitro with a synthetic vector system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Second-generation adenoviral vectors do not prevent rapid loss of transgene expression and vector DNA from the arterial wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Human adenovirus serotypes 4 and 11 show higher binding affinity and infectivity for endothelial and carcinoma cell lines than serotype 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Steps toward mapping the human vasculature by phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Enhanced gene transfer to rabbit jugular veins by an adenovirus containing a cyclic RGD motif in the HI loop of the fiber knob.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Biocompatibility of cardiovascular gene delivery catheters with adenovirus vectors: an important determinant of the efficiency of cardiovascular gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Incomplete retention after direct myocardial injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Gene delivery to the myocardium by intrapericardial injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Adenoviral gene transfer to the heart during cardiopulmonary bypass: effect of myocardial protection technique on transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Global cardiac-specific transgene expression using cardiopulmonary bypass with cardiac isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Network integration of the adrenergic system in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Beta-adrenergic stimulation induces interleukin-18 expression via beta2-AR, PI3K, Akt, IKK, and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Gene therapy for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Regulation of cardiac contractility by Rab4-modulated beta2-adrenergic receptor recycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Apoptosis: pathophysiology and therapeutic implications for the cardiac surgeon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Therapeutic inhibition of tumour necrosis factor alpha in patients with heart failure: cooling an inflamed heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Endogenous endothelium-derived nitric oxide inhibits myocardial caspase activity: implications for treatment of end-stage heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Myocardial expression of baculoviral p35 alleviates doxorubicin-induced cardiomyopathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Time course of the apoptotic cascade and effects of caspase inhibitors in adult rat ventricular cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Antiapoptotic effect of endothelin-1 in rat cardiomyocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Endothelin receptor antagonism attenuates cardiomyocyte apoptosis after induction of ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Cardiotrophin-1 phosphorylates akt and BAD, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Tyrosine kinases inhibitors block Fas-mediated deleterious effects in normoxic and hypoxic ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Expression of p300 protects cardiac myocytes from apoptosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Cardiac-specific abrogation of NF- kappa B activation in mice by transdominant expression of a mutant I kappa B alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Novel therapeutic approaches for heart failure by normalizing calcium cycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Targeting phospholamban by gene transfer in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2 )-ATPase in a rat model of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2 -ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

SERCA2A overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

In vivo adenoviral transfer of sorcin reverses cardiac contractile abnormalities of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Effects of adenovirus-mediated sorcin overexpression on excitation-contraction coupling in isolated rabbit cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Type 1 phosphatase, a negative regulator of cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Gene transfer of parvalbumin improves diastolic dysfunction in senescent myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Parvalbumin gene transfer corrects diastolic dysfunction in diseased cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Ca2 /calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2 ATPase (SERCA2a) activity and impairs cardiac function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Regulation of Sarco(endo)plasmic Reticulum Ca2 Adenosine Triphosphatase by Phospholamban and Sarcolipin Implication for Cardiac Hypertrophy and Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Micro-positron emission tomography imaging of cardiac gene expression in rats using bicistronic adenoviral vector-mediated gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Interventional magnetic resonance imaging for guiding gene and cell transfer in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

β 2 -Adrenergic Receptor Overexpression Exacerbates Development of Heart Failure After Aortic Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.3.1.85

21 January 2018

Identifiers

DOI

10.1586/14779072.3.1.85

1 reference

11 August 2017

1 reference